CGNX Cognex Corporation NASDAQ after-hours $50.78 11 Mar 2026: AI stocks view favors $68 target

CGNX stock trades at $50.78 after hours on 11 Mar 2026, reflecting firm demand for machine vision in AI-driven automation. The share price sits near its 50-day average of $44.74 and well above the 52-week low of $22.67. Volume today is 778,584 shares versus an average of 2,375,687. We use Meyka AI as an AI-powered market analysis platform to link recent earnings, analyst targets, and technicals into a concise CGNX stock outlook for NASDAQ investors in the United States.

CGNX stock: Quick market snapshot

Cognex Corporation (CGNX) trades on NASDAQ in USD with a market cap of $8.38B. The intraday range was $50.39 to $51.12, with a previous close of $50.82. Price/earnings stands at 74.38 and EPS is $0.68. Average momentum shows a 1-month gain of 16.06% and a 3-month gain of 33.42%.

CGNX stock: Fundamentals and valuation

Cognex reported trailing metrics with revenue per share of $5.95 and free cash flow per share of $1.42. The company shows a high valuation: price/sales 8.43 and price/book 5.67. Net debt is negative, and the current ratio is 3.80, which supports balance sheet strength. High P/E and price-to-free-cash-flow ratios suggest growth expectations are already priced in.

CGNX stock: Earnings, analyst targets and insider moves

Cognex beat recent quarterly EPS with $0.27 versus estimates of $0.22, and revenue hit $252.34M. Wall Street targets range from $35.00 to $70.00, with an average near $55.21. Notable insider selling occurred in February at prices near $58.00, while institutional ownership sits at 88.12%. For more background see reporting on MarketBeat and Investing.com for latest CGNX news and analyst notes: MarketBeat and Investing.com.

CGNX stock: AI opportunity and risks

Cognex leads in machine vision for factories and logistics, a clear fit for AI automation demand. Strength in automotive and electronics end markets supports medium-term revenue expansion. Risks include valuation compression if hardware spending slows and the company’s P/E of 74.38 reflects high expectations. Supply chain, cyclicality in capital spending, and execution on deep learning software remain watch points.

CGNX stock: Technical setup and trading signals

Technicals show RSI at 50.70, ADX 30.20, and MACD histogram negative, indicating mixed momentum. Bollinger bands sit 44.94 to 62.45, and ATR is 2.27, implying moderate intraday volatility. Short-term support aligns near the 50-day average at $44.74, with resistance near the 52-week high $59.88. Relative volume is 0.73, so current moves reflect above-average interest but not extreme flows.

Meyka AI rates CGNX with a score out of 100

Meyka AI rates CGNX with a score of 73.11 out of 100 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s model blends fundamentals, technicals, forecasts, and consensus to produce this score. Note that grades are informational and are not financial advice.

Final Thoughts

Key takeaways for CGNX stock: Cognex trades at $50.78 after hours on NASDAQ with strong revenue trends and healthy cash metrics. The machine vision business benefits from AI automation demand, but valuation is rich with a P/E of 74.38 and price/sales near 8.43. Analyst targets vary widely, with top targets near $68.00 to $70.00 and conservative targets near $35.00. Meyka AI’s forecast model projects a yearly price of $33.96, which implies a -33.12% downside versus the current price of $50.78; this reflects one model scenario rather than a prediction. Traders should weigh upside from continued AI-driven orders against risks from cyclical hardware spending. For live quotes and research see the Meyka CGNX page and linked market coverage. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.